Efficacy and feasibility of dose-dense neoadjuvant chemotherapy versus conventional neoadjuvant chemotherapy in patients with HER2-negative breast cancer: A single-center retrospective study

Background: Dose-dense chemotherapy (DDCT) is a standard treatment for patients with high-risk breast cancer. Although there are numerous reports regarding DDCT, it is unclear whether sequential DDCT is effective or feasible as preoperative treatment for Japanese patients. We evaluated the efficacy and safety of neoadjuvant DDCT for patients with human epidermal growth factor receptor 2 (HER2)-negative breast cancer.Methods: This retrospective study evaluated 39 patients with breast cancer, who were preoperatively treated with anthracyclinecontaining regimens and taxanes. According to the chemotherapy regimens patients were divided into the DDCT group (ddgroup) and the conventional chemotherapy (CCT) group (q3w-group). The efficacy of neoadjuvant chemotherapy was evaluated based on the pathological complete response (pCR) rate. Adverse events were evaluated according to the Common Terminology Criteria for Adverse Events version 5.0.Results: There were no apparent differences in tumor stage, histopathological subtype, or surgical procedure. There was not significant difference in the pCR rate (dd-group, 17.6%; q3w-group, 22.7%). Three-year disease-free survival rates were similar in two groups. The rates of dose reduction, delay of treatment, and discontinuation of treatment in the two groups did not differ to a statistically significant extent. There were no significant differences in the adverse events of the two groups

The effect of once-yearly zoledronic acid on hip structural and biomechanical properties derived using computed tomography (CT) in Japanese women with osteoporosis

The effects of zoledronic acid on hip structural and biomechanical properties were evaluated in Japanese patients with osteoporosis by computed tomography (CT). The subjects included in this study were a subset of female subjects (zoledronic acid group, 49 subjects; placebo group, 53 subjects) in the phase 3 trial (ZONE study) who were available for multi-detector row CT (MDCT) scanning. Eligible subjects were those diagnosed with primary osteoporosis based on the Diagnostic Criteria for Primary Osteoporosis (2000) by the Japanese Society for Bone and Mineral Research and who had between one and four fractured vertebrae located between the fourth thoracic vertebra and the fourth lumbar vertebra. The subjects received a once-yearly intravenous infusion of zoledronic acid 5 mg or placebo for two years. CT data were obtained at baseline and at 12 and 24 months later and analyzed under blinded conditions. The results demonstrated that once-yearly intravenous infusion of zoledronic acid improved volumetric bone mineral density (vBMD), cortical bone geometry parameters, and CT-derived biomechanical parameters at the femoral neck, intertrochanteric region, and shaft; particularly at the intertrochanteric region, significant improvements in cortical bone geometry parameters and CT-derived biomechanical parameters, compared with those in the placebo group, were detectable early, at 12 months. The present data suggest that zoledronic acid has a possibility to reduce the risk of hip fractures in Japanese patients with osteoporosis

Nursing Practicum Based on the Philosophy of Seirei Held at Seirei-related Welfare Facilities in the Spring Semester of the First Year at Seirei Christopher University

P(論文)聖隷看護基盤実習は、入学直後の1 年次生春セメスターに聖隷ゆかりの福祉施設などに赴き、看護を学ぶ上で基盤となる対人援助職としてのあり方を、建学の精神や聖隷の理念を礎に、学生自身の体験を振り返りながら学ぶ実習である。聖隷ゆかりの施設における臨地実習では、創設期からの歴史的な変遷や活動を知り、キリスト教精神を基盤とした建学の精神や聖隷の理念について考え、施設での出会いや語りから、対人援助職としてのあり方を、聖隷の理念と関連させて意味づけていく。 　本報告では、聖隷クリストファー大学看護基礎教育における2022 年度の聖隷看護基盤実習の創設について、①聖隷看護基盤実習の構築（看護学部学位授与方針、カリキュラムポリシー）、②単位、セメスター履修者数、③科目概要、④実習目標、⑤実習展開、⑥学内委員会・授業との連携、⑦実習記録の構成をふまえ報告する。紀要委員会企画Special Articlesdepartmental bulletin pape

聖隷クリストファー大学看護基礎教育における2020年度シミュレーション教育の実践報告

紀要委員会企画Special Articles　本報告では、聖隷クリストファー大学看護基礎教育における2020 年度のシミュレーション教育委員会の活動報告および各領域における実践について、以下の内容をふまえ報告する。　①シミュレーション教育の実践環境の構築および学内研修、②コロナ禍における通信設備・運用のテクニカルサポート、③シミュレーション教育の実践（看護学部各領域におけるシミュレーション教育の実践内容）、④看護学部シミュレーション教育ホームページ、⑤本学看護学部のシミュレーション教育に関する国内外の学会発表の実績　今後もシミュレーション教育を推進するための本学の課題である、教育環境のさらなる充実、人員の確保、地域の拠点としてのシミュレーション教育の推進、活動のための運営資金の獲得を目指すべく、近隣施設との連携、研究推進とともに、教員の理解と同意を得ながらさらなる教育環境の整備や教育力の向上のため邁進していく

Superior vena cava syndrome caused by mediastinal recurrence of breast cancer with a 13-year disease-free interval: A case report

　Superior vena cava syndrome (SVCS) is an oncological emergency. Lung cancer is the most causative malignancy. In contrast, breast cancer rarely causes SVCS. We report a case in which SVCS was caused by mediastinal lymph node metastasis of breast cancer. The patient was a 60-year-old woman who had undergone breast-conserving therapy at another hospital 13 years previously. Her breast cancer was early stage T1a(5mm)N0M0; Stage IA), and Luminal type (HER2 negative). She had received adjuvant hormone therapy, but dropped out of treatment two years and six months later. Recently, she had developed cough and face edema, and her extrajugular vein was swollen. CT revealed swollen mediastinal and supraclavicular lymph nodes, lung nodules, pericardial effusion, right pleural fluid, and stenosis of the superior vena cava (SVC). She was diagnosed with recurrent breast cancer with SVCS due to mediastinal LN swelling. A core needle biopsy of a supraclavicular lymph node revealed metastasis; the diagnosis was luminal HER2 positive breast cancer. We initiated treatment with radiotherapy for the mediastinal lymph nodes, and then started hormone therapy and anti-HER2 therapy. These therapies provided relief from her symptoms. She is currently alive and continuing hormone therapy and anti-HER2 therapy. In cases of SVCS due to malignancy, the biopsy findings should be taken into account when possible. An accurate diagnosis is extremely important for the suitable treatment of SVCS, especially in cases caused by malignancy

24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk

<p><strong>Article full text</strong></p> <p><br> The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s12325-017-0568-x"><b>here</b>.</a><br> <br> <strong>Provide enhanced digital features for this article</strong><br> If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact <u>[email protected]</u>.<br> <br> The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.<br> <br> Other enhanced features include, but are not limited to:<br> • Slide decks<br> • Videos and animations<br> • Audio abstracts<br> • Audio slides<u></u></p